Creutzfeldt-Jakob disease: Diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid

Journal of Clinical Neuroscience

Volumn 7, Issue 3, 2000, Pages 203-208

  Collins, S ^a   Boyd, A ^a   Fletcher, A ^a   Gonzales, M ^b   McLean, C A ^a   Byron, K ^b   Masters, C L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

14 3 3 proteins; Cerebrospinal fluid; Creutzfeldt Jakob disease; Prion diseases

Indexed keywords

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ACCURACY; HUMAN; MAJOR CLINICAL STUDY; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0033916370     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1054/jocn.1999.0193     Document Type: Article

References (38)

1. Brown P., Gibbs C., Rodgers-Johnson P. Ann Neurol. 35:1994;513-529.
2. Almond J., Pattison J. Human BSE. Nature. 389:1997;437-438.
3. Will R. G., Ironside J. W., Zeidler M. A new variant of Creutzfeldt-Jakob disease. Lancet. 347:1996;921-925.
4. Parchi P., Giese A., Capellari S. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 46:1999;224-233.
5. Will R. G., Alperovitch A., Poser S. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. Ann Neurol. 43:1998;763-767.
6. Windl O., Dempster M., Estibeiro J. P. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet. 98:1996;259-264.
7. Prusiner S., Hsiao K. Human prion diseases. Ann Neurol. 35:1994;385-395.
8. Kretzschmar H. A., Ironside J. W., DeArmond S. J., Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol. 53:1996;913-920.
9. Masters C. L., Harris J. O., Gajdusek D. C., Gibbs, Bernoulli C., Asher D. M. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol. 5:1979;177-188.
10. Collins S., Law M. G., Fletcher A., Boyd A., Kaldor J., Masters C. L. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet. 353:1999;693-697.
11. Zeidler M., Knight R., Stewart G. Routine tonsil biopsy for diagnosis of new variant Creutzfeldt-Jkob disease is not justified. BMJ. 318:1999;538.
12. Steinhoff B. J., Rächer S., Herrendorf G. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol. 53:1996;162-166.
13. Finkenstaedt M., Szudra A., Zerr I. MR imaging of Creutzfeldt-Jakob disease. Radiology. 199:1996;793-798.
14. Bahn M. M., Parchi P. Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. Arch Neurol. 56:1999;577-583.
15. Demaerel P., Heiner L., Robberecht W., Sciot R., Wilms G. Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease. Neurology. 52:1999;205-208.
16. Yee A. S., Simon J. H., Anderson C. A., Sze C-I., Filley C. M. Diffusion-weighted MRI of right-hemisphere dysfunction in Creutzfeldt-Jakob disease. Neurology. 52:1999;1514-1515.
17. Zerr I., Bodemer M., Räcker S. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet. 345:1995;1609-1610.
18. Harrington M., Merril C. R., Asher D. M., Gajdusek D. C. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med. 315:1986;279-283.
19. Jimi T., Wakayama Y., Shibuya S. High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzefeldt-Jakob disease. Clinica Chimica Acta. 211:1992;37-46.
20. Beaudry P., Cohen P., Brandel J. P. 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord. 10:1999;40-46.
21. Otto M., Stein H., Szudra A. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol. 244:1997;566-570.
22. Otto M., Wiltfang J., Tumani H. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett. 225:1997;210-212.
23. Hsich G., Kenney K., Gibbs, Lee K. H., Harrington M. G. Creutzfeldt-Jakob disease. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 335:1996;924-930.
24. Zerr I., Bodemer M., Weber T. The 14-3-3 brain protein and transmissible spongiform encephalopathy. N Engl J Med. 336:1997.
25. Zerr I., Bodemer M., Gefeller O. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 43:1998;32-40.
26. Manaka H., Kato T., Kurita K. Marked increase in cerebrospinal fluid ubiquitin in Creutzfeldt-Jakob disease. Neurosci Lett. 139:1992;47-49.
27. Satoh J-I., Kuohara K., Yukitake M., Kuroda Y. The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture. Eur Neurol. 41:1999;216-225.
28. Burbelo P. D., Hall A. 14-3-3 proteins: hot numbers in signal transduction. Curr Biol. 5:1995;95-96.
29. Aitken A., Collinge D. B., van Heusden B. P. H. 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins. Trends Biochem Sci. 17:1992;498-501.
30. Rosenmann H., Meiner Z., Kahana E. Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease. Neurology. 49:1997;593-595.
31. Will R. G., Zeidler M., Brown P., Harrington M., Lee K. H., Kenney K. L. Cerebrospinal-fluid test for new-variant Creutzfeldt-Jakob disease. Lancet. 348:1996;955.
32. Zeidler M., Stewart G. E., Barraclough C. R. New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet. 350:1997;903-907.
33. Collins S., Fletcher A., de Luise T., Boyd A., Masters C. L. Creutzfeldt-Jakob disease in Australia. Court L., Dodet B. Transmissible Subacute Spongiform Encephalopathies: Prion Diseases. 1996;405-415 Elsevier, Paris.
34. Hsiao K., Baker H., Crow T. Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature. 338:1989;342-345.
35. Freckman M. L., Masters C., Collins S., Boyd A., Byron K., Campbell R., Darveniza P. Predictive testing for Creutzfeldt-Jakob Disease (CJD) with a novel mutation in the prion protein gene. Human Genetics Society of Australasia. 11:1998;26.
36. Collins, S. Boyd, A. Fletcher, A. Byron, K. Harper, C. McLean, C. Masters, C. Novel prion protein gene mutation in an octogenarian with Creutzfeldt-Jakob disease. Arch Neurol (in press).
37. Schmerr M. J., Jenny A. L., Bulgin M. S. Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy. J Chromatogr. 853:1999;207-214.
38. scmolecules with different conformations. Nat Med. 4:1998;1157-1165.